認知症(Dementia)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Dementia Overview 8
Therapeutics Development 9
Pipeline Products for Dementia – Overview 9
Pipeline Products for Dementia – Comparative Analysis 10
Dementia – Therapeutics under Development by Companies 11
Dementia – Therapeutics under Investigation by Universities/Institutes 14
Dementia – Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Dementia – Products under Development by Companies 19
Dementia – Products under Investigation by Universities/Institutes 22
Dementia – Companies Involved in Therapeutics Development 23
Actinogen Limited 23
Alector LLC 24
AlzProtect SAS 25
BioArctic Neuroscience AB 26
Biogen Idec Inc. 27
Biotie Therapies Corp. 28
Bristol-Myers Squibb Company 29
Chase Pharmaceuticals Corporation 30
Chronos Therapeutics Limited 31
Daewoong Pharmaceutical Co., Ltd. 32
Echo Pharmaceuticals B.V. 33
Eisai Co., Ltd. 34
FORUM Pharmaceuticals Inc. 35
Hyundai Pharmaceutical Co., Ltd. 36
Ildong Pharmaceutical Co., Ltd. 37
IMMD Inc. 38
ImStar Therapeutics Inc. 39
Integrative Research Laboratories Sweden AB 40
Intellect Neurosciences, Inc. 41
Intra-Cellular Therapies, Inc. 42
Neurimmune Holding AG 43
Oryzon Genomics S.A. 44
Otsuka Holdings Co., Ltd. 45
Pacific Northwest Biotechnology, LLC 46
ProteoTech, Inc. 47
SK Chemicals Co., Ltd. 48
Stelic Institute & Co. 49
Sumitomo Dainippon Pharma Co., Ltd. 50
Sylentis S.A. 51
TauRx Therapeutics Ltd. 52
Tautatis Incorporated 53
Varinel, Inc. 54
WhanIn Pharmaceutical Co., Ltd. 55
Dementia – Therapeutics Assessment 56
Assessment by Monotherapy Products 56
Assessment by Target 57
Assessment by Mechanism of Action 60
Assessment by Route of Administration 62
Assessment by Molecule Type 64
Drug Profiles 66
Antisense Oligonucleotide to Inhibit microRNA for Neurology – Drug Profile 66
aripiprazole – Drug Profile 67
AVCRI-104P3 – Drug Profile 70
AZP-2006 – Drug Profile 71
brexpiprazole – Drug Profile 73
choline alfoscerate SR – Drug Profile 75
CPC-201 – Drug Profile 76
CPC-252 – Drug Profile 77
dehydroevodiamine hydrochloride – Drug Profile 78
dronabinol – Drug Profile 79
Drugs for Dementia – Drug Profile 81
Drugs to Agonize c-MET for Dementia – Drug Profile 82
Drugs to Inhibit Matrix Metalloproteinase for Dementia and Cognitive Impairment – Drug Profile 83
DWJ-1365 – Drug Profile 84
E-2609 – Drug Profile 85
encenicline hydrochloride – Drug Profile 86
FRM-0334 – Drug Profile 89
GIBH-130 – Drug Profile 91
gugulipid – Drug Profile 92
IIPP-1 – Drug Profile 93
IMD-4482 – Drug Profile 94
IPN-007 – Drug Profile 95
IRL-752 – Drug Profile 96
ITI-007 – Drug Profile 97
KR-12 – Drug Profile 99
Monoclonal Antibodies for Dementia and Alzheimer’s Disease – Drug Profile 100
Monoclonal Antibodies to Inhibit Tau for CNS Disorders – Drug Profile 101
NAT – Drug Profile 102
NI-205 – Drug Profile 103
NI-308 – Drug Profile 104
NNC-269100 – Drug Profile 105
OG-635 – Drug Profile 106
PD-0805 – Drug Profile 107
PD-61W3 – Drug Profile 108
PD-61W3 Backup – Drug Profile 109
Peptide to Inhibit BACE for Cerebropathy and Dementia – Drug Profile 110
PST-900 – Drug Profile 111
RDC-5 – Drug Profile 112
RNAi Oligonucleotide for Cerebral Ischemia and Dementia – Drug Profile 114
SID-111 – Drug Profile 115
Small Molecule to Activate LPL for CNS and Metabolic Disorders – Drug Profile 116
Small Molecule to Inhibit Glycogene 5 for Dementia – Drug Profile 117
Small Molecules for Ophthalmology and CNS Disorders – Drug Profile 118
Small Molecules to Inhibit LSD-1 And MAO-B for Neurodegenerative Diseases – Drug Profile 119
Small Molecules to Inhibit TANA for ALS, Dementia and Alzheimer’s Disease – Drug Profile 120
SYN-120 – Drug Profile 121
Synthetic Peptides for Neurological Disorders – Drug Profile 122
TAK-070 – Drug Profile 123
TauC-3 – Drug Profile 124
TPI-287 – Drug Profile 125
TRx-0237 – Drug Profile 127
TTT-3002 – Drug Profile 129
UE-2343 – Drug Profile 130
VAR-10100 – Drug Profile 131
WIB-1001C – Drug Profile 132
zonisamide – Drug Profile 133
Dementia – Recent Pipeline Updates 134
Dementia – Dormant Projects 150
Dementia – Discontinued Products 152
Dementia – Product Development Milestones 153
Featured News & Press Releases 153
Appendix 161
Methodology 161
Coverage 161
Secondary Research 161
Primary Research 161
Expert Panel Validation 161
Contact Us 162
Disclaimer 162